Brief: Nextcell Pharma Q1 Operating Loss At SEK 17.7 Mln

NextCell Pharma AB

29/01/2021 07:37

Jan 29 (Reuters) - NextCell Pharma AB  NXTCL.ST :
    * Q1 LOSS PER SHARE 0.23 SEK
    * NEXTCELL PHARMA PUBLISHES INTERIM REPORT 1 2020/2021
    * Q1 OPERATING INCOME AMOUNTED TO SEK 1 148 187 (1 222 087)
    * Q1 OPERATING RESULT AMOUNTED TO SEK -17 680 697 (-17 997
787)

Source text for Eikon:  ID:nWkr1HcZ0s 
Further company coverage:  NXTCL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))